Quarterly report pursuant to Section 13 or 15(d)

Condensed Balance Sheets (Unaudited)

v3.20.2
Condensed Balance Sheets (Unaudited) - USD ($)
Jun. 30, 2020
Dec. 31, 2019
Current Assets    
Cash $ 19,628,685 $ 25,063
Accounts receivable 3,086,402 2,075,380
Factor receivables, net 388,364 174,042
Inventory 1,855,595 2,215,497
Prepaid assets 1,792,666 254,070
Note receivable 1,480,000 4,480,000
Total Current Assets 28,231,712 9,224,052
Property and equipment, net 1,598,583 1,029,885
Other assets 470,688 215,688
Total Assets 30,300,983 10,469,625
Current Liabilities    
Accounts payable 2,105,052 2,536,871
Accrued expenses 404,197 364,309
Factor loan payable 294,868 125,645
Convertible notes payable, net of discount 1,759,081 4,216,307
Total Current Liabilities 4,563,198 7,243,132
Total Liabilities 4,563,198 7,243,132
Shareholders' Equity    
Common stock, $0.0001 par value, 200,000,000 shares authorized, 38,414,631 and 3,300,015 shares issued and outstanding at June 30, 2020 and December 31, 2019, respectively 3,842 330
Additional paid-in capital 75,421,130 41,823,048
Accumulated deficit (49,687,187) (43,413,370)
Total Shareholders' Equity 25,737,785 3,226,493
Total Liabilities and Shareholders' Equity 30,300,983 10,469,625
Series D Preferred Stock [Member]    
Shareholders' Equity    
Preferred Stock value 4,816,485
Total Shareholders' Equity $ 4,816,485